Skip to main content
. 2022 Sep 14;13:972590. doi: 10.3389/fneur.2022.972590

Table 1.

Participants' demographic and clinical characteristics.

FBTCS-Y
(19)
FBTCS-N
(8)
Controls
(20)
Age* (M ± SD) 38 ± 10.88 46 ± 15.21 37 ± 11.42
Sex (M / F) 8 / 11 3 / 5 5 / 15
Onset side (L / R / U) 8 / 9 / 2 3 / 3 / 2 NA
Onset age (M ± SD) 18 ± 14.36 30 ± 20.96 NA
Disease duration (M ± SD) 27 ± 16.14 22 ± 12.31 NA
Drug resistant (Y / N) 14 / 5 4 / 4 NA
Auras 11 7 NA
MRI findings
Normal 11 4 NA
MCD 4 1 NA
CD/FCD 2 1 NA
Hippocampal cyst 1 (R) 1 (L) NA
Various (PVH, DNET) 1 1 NA
Epilepsy classification
Frontal (L / R) 2 / 2 0 NA
Temporal (L / R) 1 / 2 0 NA
Parietal (L / R) 1 / 1 2 (R) NA
Occipital (L / R) 1 / 1 1 (L) NA
Frontotemporal (L / R / U) 3 / 2 1 / 1 / 1 NA
Frontocentral (L / R) 1 (L) 1 (L) NA
Unknown 2 1 NA

Key: L, left; R, right, U, unknown; “*”, age at MRI scan; CD, cortical dysplasia. DNET, dysembryoplastic neuroepithelial tumor; FCD, focal cortical dysplasia; MCD, malformations of cortical development; PVH, periventricular heterotopia. Two patients and one control were removed after failing the QC tests.